KALA BIO, Inc.
What this means
- Exchange listing at riskOn Aug 28, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Quarterly report lateOn Nov 13, 2026 the company filed Form NT 10-Q: it could not file its quarterly report on time. Rule 12b-25 gives an extra 15 calendar days for an annual report and 5 for a quarterly report. We have no later report from the company yet.
- Change of auditorOn Dec 29, 2025 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
- Change in controlOn Feb 2, 2026 the company reported a change in control (Item 5.01).
- Net loss in 2025Net loss of $27M for the year (2024: −$38.5M).
- Private capital raiseOn Mar 17, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.
What to do next
- NT 10-K: what a late-filing notice actually meansguide
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$27M | −$38.5M |
| Total assets | $9.5M | $55.5M |
| Total liabilities | $2.5M | $43.2M |
| Stockholders’ equity | $7M | $12.3M |
| Cash and equivalents | $7.6M | $51.2M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- KALA BIO, Inc.
Formerly: KALA BIO, Inc. - CIK
- 0001479419
- Tickers
- KALA
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Arlington, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Jun 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 13, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form NT 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
- Form 8-K · items 3.01 · filed Aug 28, 2026 · filing
- Form 10-Q · filed Aug 19, 2026 · filing
- Form NT 10-Q · filed Aug 14, 2026 · filing
- Form 10-Q · filed May 15, 2026 · filing
- Form 10-K · filed Apr 15, 2026 · filing
- Form NT 10-K · filed Mar 31, 2026 · filing
- Form D · items 06b · filed Mar 17, 2026 · filing
- Form 8-K · items 5.02 · filed Feb 20, 2026 · filing
- Form D · items 06b · filed Feb 13, 2026 · filing
- Form SCHEDULE 13D · filed Feb 6, 2026 · filing
- Form 8-K · items 5.02 · filed Feb 5, 2026 · filing
- Form 8-K · items 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01 · filed Feb 2, 2026 · filing
- Form 8-K · items 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01 · filed Feb 2, 2026 · filing
- Form 8-K · items 3.01 · filed Jan 23, 2026 · filing
- Form 8-K · items 4.01, 5.02 · filed Dec 29, 2025 · filing
- Form 8-K · items 4.01, 5.02 · filed Dec 29, 2025 · filing
- Form 8-K · items 4.01, 9.01 · filed Dec 16, 2025 · filing
- Form 8-K · items 1.01, 1.02, 2.03, 3.02, 5.02, 5.03, 9.01 · filed Nov 25, 2025 · filing
- Form 10-Q · filed Nov 19, 2025 · filing
- Form NT 10-Q · filed Nov 14, 2025 · filing
- Form 8-K · items 3.01 · filed Nov 12, 2025 · filing
- Form 8-K · items 2.05, 5.02, 8.01 · filed Oct 20, 2025 · filing
- Form 8-K · items 2.05, 5.02, 8.01 · filed Oct 20, 2025 · filing
- Form 8-K · items 2.04 · filed Oct 1, 2025 · filing
- Form 8-K · items 2.05, 8.01, 9.01 · filed Sep 29, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Sep 2, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 8, 2025 · filing
- Form 10-Q · filed Aug 8, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
- Form 10-Q · filed May 14, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Apr 11, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 31, 2025 · filing
- Form 10-K · filed Mar 31, 2025 · filing
- Form 8-K · items 5.02 · filed Feb 12, 2025 · filing
- Form D · items 06b · filed Dec 31, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 5.02 · filed Sep 25, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
- Form 10-Q · filed Aug 6, 2024 · filing
- Form SC 13D · filed Jul 8, 2024 · filing
- Form SC 13D · filed Jun 28, 2024 · filing
- Form D · items 06b · filed Jun 28, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2024 · filing
- Form 10-Q · filed May 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 29, 2024 · filing
- Form 10-K · filed Mar 29, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2023 · filing
- Form 10-Q · filed Nov 13, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 4, 2023 · filing
- Form 10-Q · filed Aug 4, 2023 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 23, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 9, 2023 · filing
- Form 10-Q · filed May 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 3, 2023 · filing
- Form 10-K · filed Mar 3, 2023 · filing